These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 15981215)

  • 1. Antibody response to a non-conserved C-terminal part of human histone deacetylase 3 in colon cancer patients.
    Shebzukhov YV; Koroleva EP; Khlgatian SV; Belousov PV; Kuz'mina KE; Radko BV; Longpre F; Lagarkova MA; Kadachigova TS; Gurova OV; Meshcheryakov AA; Lichinitser MR; Knuth A; Jager E; Kuprash DV; Nedospasov SA
    Int J Cancer; 2005 Dec; 117(5):800-6. PubMed ID: 15981215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Colon cancer cells maintain low levels of pyruvate to avoid cell death caused by inhibition of HDAC1/HDAC3.
    Thangaraju M; Carswell KN; Prasad PD; Ganapathy V
    Biochem J; 2009 Jan; 417(1):379-89. PubMed ID: 18789002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel tumor antigens identified by autologous antibody screening of childhood medulloblastoma cDNA libraries.
    Behrends U; Schneider I; Rössler S; Frauenknecht H; Golbeck A; Lechner B; Eigenstetter G; Zobywalski C; Müller-Weihrich S; Graubner U; Schmid I; Sackerer D; Späth M; Goetz C; Prantl F; Asmuss HP; Bise K; Mautner J
    Int J Cancer; 2003 Aug; 106(2):244-51. PubMed ID: 12800201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toward selective histone deacetylase inhibitor design: homology modeling, docking studies, and molecular dynamics simulations of human class I histone deacetylases.
    Wang DF; Helquist P; Wiech NL; Wiest O
    J Med Chem; 2005 Nov; 48(22):6936-47. PubMed ID: 16250652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer-related serological recognition of human colon cancer: identification of potential diagnostic and immunotherapeutic targets.
    Scanlan MJ; Welt S; Gordon CM; Chen YT; Gure AO; Stockert E; Jungbluth AA; Ritter G; Jäger D; Jäger E; Knuth A; Old LJ
    Cancer Res; 2002 Jul; 62(14):4041-7. PubMed ID: 12124339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Homo-oligomerisation and nuclear localisation of mouse histone deacetylase 1.
    Taplick J; Kurtev V; Kroboth K; Posch M; Lechner T; Seiser C
    J Mol Biol; 2001 Apr; 308(1):27-38. PubMed ID: 11302704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HDAC3 overexpression and colon cancer cell proliferation and differentiation.
    Spurling CC; Godman CA; Noonan EJ; Rasmussen TP; Rosenberg DW; Giardina C
    Mol Carcinog; 2008 Feb; 47(2):137-47. PubMed ID: 17849419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential display cloning of a novel human histone deacetylase (HDAC3) cDNA from PHA-activated immune cells.
    Dangond F; Hafler DA; Tong JK; Randall J; Kojima R; Utku N; Gullans SR
    Biochem Biophys Res Commun; 1998 Jan; 242(3):648-52. PubMed ID: 9464271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Type-specific roles of histone deacetylase (HDAC) overexpression in ovarian carcinoma: HDAC1 enhances cell proliferation and HDAC3 stimulates cell migration with downregulation of E-cadherin.
    Hayashi A; Horiuchi A; Kikuchi N; Hayashi T; Fuseya C; Suzuki A; Konishi I; Shiozawa T
    Int J Cancer; 2010 Sep; 127(6):1332-46. PubMed ID: 20049841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibodies elicited by naked DNA vaccination against the complementary-determining region 3 hypervariable region of immunoglobulin heavy chain idiotypic determinants of B-lymphoproliferative disorders specifically react with patients' tumor cells.
    Rinaldi M; Ria F; Parrella P; Signori E; Serra A; Ciafrè SA; Vespignani I; Lazzari M; Farace MG; Saglio G; Fazio VM
    Cancer Res; 2001 Feb; 61(4):1555-62. PubMed ID: 11245465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human tankyrases are aberrantly expressed in colon tumors and contain multiple epitopes that induce humoral and cellular immune responses in cancer patients.
    Shebzukhov YV; Lavrik IN; Karbach J; Khlgatian SV; Koroleva EP; Belousov PV; Kashkin KN; Knuth A; Jager E; Chi NW; Kuprash DV; Nedospasov SA
    Cancer Immunol Immunother; 2008 Jun; 57(6):871-81. PubMed ID: 18026951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cryptic epitopes induce high-titer humoral immune response in patients with cancer.
    Fischer E; Kobold S; Kleber S; Kubuschok B; Braziulis E; Knuth A; Renner C; Wadle A
    J Immunol; 2010 Sep; 185(5):3095-102. PubMed ID: 20660712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Humoral immunity against a tandem repeat epitope of human mucin MUC-1 in sera from breast, pancreatic, and colon cancer patients.
    Kotera Y; Fontenot JD; Pecher G; Metzgar RS; Finn OJ
    Cancer Res; 1994 Jun; 54(11):2856-60. PubMed ID: 7514493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of human colon cancer antigens recognized by autologous antibodies.
    Scanlan MJ; Chen YT; Williamson B; Gure AO; Stockert E; Gordan JD; Türeci O; Sahin U; Pfreundschuh M; Old LJ
    Int J Cancer; 1998 May; 76(5):652-8. PubMed ID: 9610721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Class I histone deacetylase expression has independent prognostic impact in human colorectal cancer: specific role of class I histone deacetylases in vitro and in vivo.
    Weichert W; Röske A; Niesporek S; Noske A; Buckendahl AC; Dietel M; Gekeler V; Boehm M; Beckers T; Denkert C
    Clin Cancer Res; 2008 Mar; 14(6):1669-77. PubMed ID: 18347167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serological analysis of human anti-human antibody responses in colon cancer patients treated with repeated doses of humanized monoclonal antibody A33.
    Ritter G; Cohen LS; Williams C; Richards EC; Old LJ; Welt S
    Cancer Res; 2001 Sep; 61(18):6851-9. PubMed ID: 11559561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Humoral immune responses against tumor-associated antigen OVA66 originally defined by serological analysis of recombinant cDNA expression libraries and its potentiality in cellular immunity.
    Jin S; Wang Y; Zhang Y; Zhang HZ; Wang SJ; Tang JQ; Chen HJ; Ge HL
    Cancer Sci; 2008 Aug; 99(8):1670-8. PubMed ID: 18754882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mammalian histone deacetylase 1 protein is posttranslationally modified by phosphorylation.
    Cai R; Kwon P; Yan-Neale Y; Sambuccetti L; Fischer D; Cohen D
    Biochem Biophys Res Commun; 2001 May; 283(2):445-53. PubMed ID: 11327722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoclonal antibodies recognizing epitopes of calretinins: dependence on Ca2+-binding status and differences in antigen accessibility in colon cancer cells.
    Zimmermann L; Schwaller B
    Cell Calcium; 2002 Jan; 31(1):13-25. PubMed ID: 11990296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunization with an antigen identified by cytokine tumor vaccine-assisted SEREX (CAS) suppressed growth of the rat 9L glioma in vivo.
    Okada H; Attanucci J; Giezeman-Smits KM; Brissette-Storkus C; Fellows WK; Gambotto A; Pollack LF; Pogue-Geile K; Lotze MT; Bozik ME; Chambers WH
    Cancer Res; 2001 Mar; 61(6):2625-31. PubMed ID: 11289140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.